P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
Автори: | Rafat Abonour, Robert Rifkin, Sikander Ailawadhi, Hans C. Lee, Christina Gasparetto, Lynne Wagner, Brian Durie, James Hardin, Howard Terebelo, Mohit Narang, Kathleen Toomey, Yuexin Tang, Sujith Dhanasiri, Jasmeet Anand, Edward Yu, Thomas Marshall, Liang Liu, Sundar Jagannath |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Wiley
2023-08-01
|
Серія: | HemaSphere |
Онлайн доступ: | http://journals.lww.com/10.1097/01.HS9.0000970564.52503.e2 |
Схожі ресурси
Схожі ресурси
-
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
за авторством: Sikander Ailawadhi, та інші
Опубліковано: (2024-11-01) -
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
за авторством: Hans C. Lee, та інші
Опубліковано: (2021-07-01) -
Connect MM Registry as a national reference for United States multiple myeloma patients
за авторством: Sikander Ailawadhi, та інші
Опубліковано: (2020-01-01) -
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
за авторством: Sundar Jagannath, та інші
Опубліковано: (2018-07-01) -
Lenalidomide-Associated ITP
за авторством: Christina I. Herold, та інші
Опубліковано: (2011-01-01)